Research programme: raptamer-drug conjugates - Champions Oncology/Fannin Innovation Studio
Alternative Names: DNA-Drug Conjugates; next generation Raptamer-Drug Conjugates; RDCsLatest Information Update: 11 Feb 2022
At a glance
- Originator Champions Oncology; Fannin Innovation Studio
- Class Antineoplastics; DNA; Drug conjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer